▶ 調査レポート

肺/呼吸器ドラッグデリバリーの世界市場(~2026年)

• 英文タイトル:Global Pulmonary/ Respiratory Drug Delivery Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。肺/呼吸器ドラッグデリバリーの世界市場(~2026年) / Global Pulmonary/ Respiratory Drug Delivery Market Size, Status and Forecast 2020-2026 / MRC2-11QY04417資料のイメージです。• レポートコード:MRC2-11QY04417
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は肺/呼吸器ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別(懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤)市場規模、用途別(病院、在宅ケア)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別肺/呼吸器ドラッグデリバリーの競争状況、市場シェア
・世界の肺/呼吸器ドラッグデリバリー市場:種類別市場規模 2015年-2020年(懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤)
・世界の肺/呼吸器ドラッグデリバリー市場:種類別市場規模予測 2021年-2026年(懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤)
・世界の肺/呼吸器ドラッグデリバリー市場:用途別市場規模 2015年-2020年(病院、在宅ケア)
・世界の肺/呼吸器ドラッグデリバリー市場:用途別市場規模予測 2021年-2026年(病院、在宅ケア)
・北米の肺/呼吸器ドラッグデリバリー市場分析:米国、カナダ
・ヨーロッパの肺/呼吸器ドラッグデリバリー市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの肺/呼吸器ドラッグデリバリー市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の肺/呼吸器ドラッグデリバリー市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの肺/呼吸器ドラッグデリバリー市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Merck、Teva Pharmaceutical、3M、Astrazeneca、Boehringer Ingelheim、Cipla、Glaxosmithkline、Novartis、Omron Corporation、Sunovion Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Pulmonary/ Respiratory Drug Delivery Market
The global Pulmonary/ Respiratory Drug Delivery market size is projected to reach US$ 32810 million by 2026, from US$ 31560 million in 2020, at a CAGR of 3.7%% during 2021-2026.

Global Pulmonary/ Respiratory Drug Delivery Scope and Market Size
Pulmonary/ Respiratory Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary/ Respiratory Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Teva Pharmaceutical
3M
Astrazeneca
Boehringer Ingelheim
Cipla
Glaxosmithkline
Novartis
Omron Corporation
Sunovion Pharmaceuticals

Market segment by Type, the product can be split into
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
Market segment by Application, split into
Hospitals
Home Care

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pulmonary/ Respiratory Drug Delivery Revenue
1.4 Market by Type
1.4.1 Global Pulmonary/ Respiratory Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Suspension Aerosol
1.4.3 Solution Aerosol
1.4.4 Dry Powder Formulation
1.5 Market by Application
1.5.1 Global Pulmonary/ Respiratory Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Home Care
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Pulmonary/ Respiratory Drug Delivery Market Perspective (2015-2026)
2.2 Global Pulmonary/ Respiratory Drug Delivery Growth Trends by Regions
2.2.1 Pulmonary/ Respiratory Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pulmonary/ Respiratory Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pulmonary/ Respiratory Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Pulmonary/ Respiratory Drug Delivery Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pulmonary/ Respiratory Drug Delivery Players by Market Size
3.1.1 Global Top Pulmonary/ Respiratory Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Pulmonary/ Respiratory Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pulmonary/ Respiratory Drug Delivery Market Concentration Ratio
3.2.1 Global Pulmonary/ Respiratory Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pulmonary/ Respiratory Drug Delivery Revenue in 2019
3.3 Pulmonary/ Respiratory Drug Delivery Key Players Head office and Area Served
3.4 Key Players Pulmonary/ Respiratory Drug Delivery Product Solution and Service
3.5 Date of Enter into Pulmonary/ Respiratory Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pulmonary/ Respiratory Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)
5.2 Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pulmonary/ Respiratory Drug Delivery Market Size (2015-2020)
6.2 Pulmonary/ Respiratory Drug Delivery Key Players in North America (2019-2020)
6.3 North America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020)
6.4 North America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pulmonary/ Respiratory Drug Delivery Market Size (2015-2020)
7.2 Pulmonary/ Respiratory Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)

8 China
8.1 China Pulmonary/ Respiratory Drug Delivery Market Size (2015-2020)
8.2 Pulmonary/ Respiratory Drug Delivery Key Players in China (2019-2020)
8.3 China Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020)
8.4 China Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pulmonary/ Respiratory Drug Delivery Market Size (2015-2020)
9.2 Pulmonary/ Respiratory Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size (2015-2020)
10.2 Pulmonary/ Respiratory Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)

11 India
11.1 India Pulmonary/ Respiratory Drug Delivery Market Size (2015-2020)
11.2 Pulmonary/ Respiratory Drug Delivery Key Players in India (2019-2020)
11.3 India Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020)
11.4 India Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pulmonary/ Respiratory Drug Delivery Market Size (2015-2020)
12.2 Pulmonary/ Respiratory Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Pulmonary/ Respiratory Drug Delivery Introduction
13.1.4 Merck Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Details
13.2.2 Teva Pharmaceutical Business Overview
13.2.3 Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Introduction
13.2.4 Teva Pharmaceutical Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.2.5 Teva Pharmaceutical Recent Development
13.3 3M
13.3.1 3M Company Details
13.3.2 3M Business Overview
13.3.3 3M Pulmonary/ Respiratory Drug Delivery Introduction
13.3.4 3M Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.3.5 3M Recent Development
13.4 Astrazeneca
13.4.1 Astrazeneca Company Details
13.4.2 Astrazeneca Business Overview
13.4.3 Astrazeneca Pulmonary/ Respiratory Drug Delivery Introduction
13.4.4 Astrazeneca Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.4.5 Astrazeneca Recent Development
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Details
13.5.2 Boehringer Ingelheim Business Overview
13.5.3 Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Introduction
13.5.4 Boehringer Ingelheim Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.5.5 Boehringer Ingelheim Recent Development
13.6 Cipla
13.6.1 Cipla Company Details
13.6.2 Cipla Business Overview
13.6.3 Cipla Pulmonary/ Respiratory Drug Delivery Introduction
13.6.4 Cipla Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.6.5 Cipla Recent Development
13.7 Glaxosmithkline
13.7.1 Glaxosmithkline Company Details
13.7.2 Glaxosmithkline Business Overview
13.7.3 Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Introduction
13.7.4 Glaxosmithkline Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.7.5 Glaxosmithkline Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Pulmonary/ Respiratory Drug Delivery Introduction
13.8.4 Novartis Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Omron Corporation
13.9.1 Omron Corporation Company Details
13.9.2 Omron Corporation Business Overview
13.9.3 Omron Corporation Pulmonary/ Respiratory Drug Delivery Introduction
13.9.4 Omron Corporation Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.9.5 Omron Corporation Recent Development
13.10 Sunovion Pharmaceuticals
13.10.1 Sunovion Pharmaceuticals Company Details
13.10.2 Sunovion Pharmaceuticals Business Overview
13.10.3 Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Introduction
13.10.4 Sunovion Pharmaceuticals Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020)
13.10.5 Sunovion Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Pulmonary/ Respiratory Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Pulmonary/ Respiratory Drug Delivery Revenue
Table 3. Ranking of Global Top Pulmonary/ Respiratory Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pulmonary/ Respiratory Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Suspension Aerosol
Table 6. Key Players of Solution Aerosol
Table 7. Key Players of Dry Powder Formulation
Table 8. Global Pulmonary/ Respiratory Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pulmonary/ Respiratory Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pulmonary/ Respiratory Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions (2015-2020)
Table 12. Global Pulmonary/ Respiratory Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pulmonary/ Respiratory Drug Delivery Market Growth Strategy
Table 18. Main Points Interviewed from Key Pulmonary/ Respiratory Drug Delivery Players
Table 19. Global Pulmonary/ Respiratory Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 20. Global Pulmonary/ Respiratory Drug Delivery Market Share by Players (2015-2020)
Table 21. Global Top Pulmonary/ Respiratory Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary/ Respiratory Drug Delivery as of 2019)
Table 22. Global Pulmonary/ Respiratory Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pulmonary/ Respiratory Drug Delivery Product Solution and Service
Table 25. Date of Enter into Pulmonary/ Respiratory Drug Delivery Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 28. Global Pulmonary/ Respiratory Drug Delivery Market Size Share by Type (2015-2020)
Table 29. Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share by Type (2021-2026)
Table 30. Global Pulmonary/ Respiratory Drug Delivery Market Size Share by Application (2015-2020)
Table 31. Global Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 32. Global Pulmonary/ Respiratory Drug Delivery Market Size Share by Application (2021-2026)
Table 33. North America Key Players Pulmonary/ Respiratory Drug Delivery Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Pulmonary/ Respiratory Drug Delivery Market Share (2019-2020)
Table 35. North America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 36. North America Pulmonary/ Respiratory Drug Delivery Market Share by Type (2015-2020)
Table 37. North America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 38. North America Pulmonary/ Respiratory Drug Delivery Market Share by Application (2015-2020)
Table 39. Europe Key Players Pulmonary/ Respiratory Drug Delivery Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Pulmonary/ Respiratory Drug Delivery Market Share (2019-2020)
Table 41. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Pulmonary/ Respiratory Drug Delivery Market Share by Type (2015-2020)
Table 43. Europe Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Pulmonary/ Respiratory Drug Delivery Market Share by Application (2015-2020)
Table 45. China Key Players Pulmonary/ Respiratory Drug Delivery Revenue (2019-2020) (Million US$)
Table 46. China Key Players Pulmonary/ Respiratory Drug Delivery Market Share (2019-2020)
Table 47. China Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 48. China Pulmonary/ Respiratory Drug Delivery Market Share by Type (2015-2020)
Table 49. China Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 50. China Pulmonary/ Respiratory Drug Delivery Market Share by Application (2015-2020)
Table 51. Japan Key Players Pulmonary/ Respiratory Drug Delivery Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Pulmonary/ Respiratory Drug Delivery Market Share (2019-2020)
Table 53. Japan Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Pulmonary/ Respiratory Drug Delivery Market Share by Type (2015-2020)
Table 55. Japan Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Pulmonary/ Respiratory Drug Delivery Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Pulmonary/ Respiratory Drug Delivery Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Pulmonary/ Respiratory Drug Delivery Market Share (2019-2020)
Table 59. Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Share by Type (2015-2020)
Table 61. Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Share by Application (2015-2020)
Table 63. India Key Players Pulmonary/ Respiratory Drug Delivery Revenue (2019-2020) (Million US$)
Table 64. India Key Players Pulmonary/ Respiratory Drug Delivery Market Share (2019-2020)
Table 65. India Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 66. India Pulmonary/ Respiratory Drug Delivery Market Share by Type (2015-2020)
Table 67. India Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 68. India Pulmonary/ Respiratory Drug Delivery Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Pulmonary/ Respiratory Drug Delivery Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Pulmonary/ Respiratory Drug Delivery Market Share (2019-2020)
Table 71. Central & South America Pulmonary/ Respiratory Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Pulmonary/ Respiratory Drug Delivery Market Share by Type (2015-2020)
Table 73. Central & South America Pulmonary/ Respiratory Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Pulmonary/ Respiratory Drug Delivery Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. Teva Pharmaceutical Company Details
Table 81. Teva Pharmaceutical Business Overview
Table 82. Teva Pharmaceutical Product
Table 83. Teva Pharmaceutical Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 84. Teva Pharmaceutical Recent Development
Table 85. 3M Company Details
Table 86. 3M Business Overview
Table 87. 3M Product
Table 88. 3M Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 89. 3M Recent Development
Table 90. Astrazeneca Company Details
Table 91. Astrazeneca Business Overview
Table 92. Astrazeneca Product
Table 93. Astrazeneca Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 94. Astrazeneca Recent Development
Table 95. Boehringer Ingelheim Company Details
Table 96. Boehringer Ingelheim Business Overview
Table 97. Boehringer Ingelheim Product
Table 98. Boehringer Ingelheim Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 99. Boehringer Ingelheim Recent Development
Table 100. Cipla Company Details
Table 101. Cipla Business Overview
Table 102. Cipla Product
Table 103. Cipla Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 104. Cipla Recent Development
Table 105. Glaxosmithkline Company Details
Table 106. Glaxosmithkline Business Overview
Table 107. Glaxosmithkline Product
Table 108. Glaxosmithkline Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 109. Glaxosmithkline Recent Development
Table 110. Novartis Business Overview
Table 111. Novartis Product
Table 112. Novartis Company Details
Table 113. Novartis Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 114. Novartis Recent Development
Table 115. Omron Corporation Company Details
Table 116. Omron Corporation Business Overview
Table 117. Omron Corporation Product
Table 118. Omron Corporation Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 119. Omron Corporation Recent Development
Table 120. Sunovion Pharmaceuticals Company Details
Table 121. Sunovion Pharmaceuticals Business Overview
Table 122. Sunovion Pharmaceuticals Product
Table 123. Sunovion Pharmaceuticals Revenue in Pulmonary/ Respiratory Drug Delivery Business (2015-2020) (Million US$)
Table 124. Sunovion Pharmaceuticals Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary/ Respiratory Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Suspension Aerosol Features
Figure 3. Solution Aerosol Features
Figure 4. Dry Powder Formulation Features
Figure 5. Global Pulmonary/ Respiratory Drug Delivery Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Home Care Case Studies
Figure 8. Pulmonary/ Respiratory Drug Delivery Report Years Considered
Figure 9. Global Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 11. Global Pulmonary/ Respiratory Drug Delivery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pulmonary/ Respiratory Drug Delivery Market Share by Players in 2019
Figure 14. Global Top Pulmonary/ Respiratory Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary/ Respiratory Drug Delivery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pulmonary/ Respiratory Drug Delivery Revenue in 2019
Figure 16. North America Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pulmonary/ Respiratory Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed